No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr3:75608000-75608600 |
Enhancers |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
2 |
chr3:75625600-75626000 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
3 |
chr3:75625600-75628000 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
4 |
chr3:75625800-75626800 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
5 |
chr3:75626000-75627400 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
6 |
chr3:75626800-75628200 |
Weak transcription |
Breast Myoepithelial Primary Cells |
Breast
|
7 |
chr3:75627400-75628200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
8 |
chr3:75628000-75629000 |
Flanking Active TSS |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
9 |
chr3:75628200-75628400 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
10 |
chr3:75628200-75628400 |
Flanking Active TSS |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
11 |
chr3:75628200-75628400 |
Bivalent Enhancer |
Fetal Kidney |
kidney
|
12 |
chr3:75628200-75629400 |
Bivalent/Poised TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
13 |
chr3:75628400-75628600 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
14 |
chr3:75628400-75628600 |
Bivalent/Poised TSS |
H9 Cell Line |
embryonic stem cell
|
15 |
chr3:75628400-75628600 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
16 |
chr3:75628400-75628600 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
17 |
chr3:75628400-75628600 |
Bivalent Enhancer |
Primary hematopoietic stem cells short term culture |
blood
|
18 |
chr3:75628400-75628600 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
19 |
chr3:75628400-75629400 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
20 |
chr3:75628400-75629400 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
21 |
chr3:75628400-75629400 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
22 |
chr3:75628400-75629400 |
Bivalent/Poised TSS |
iPS-18 Cell Line |
embryonic stem cell
|
23 |
chr3:75628400-75629600 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
24 |
chr3:75628400-75629600 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
25 |
chr3:75628400-75629600 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
26 |
chr3:75628400-75629600 |
Active TSS |
Breast Myoepithelial Primary Cells |
Breast
|
27 |
chr3:75628400-75629600 |
Active TSS |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
28 |
chr3:75628400-75629800 |
Active TSS |
Brain Cingulate Gyrus |
brain
|
29 |
chr3:75628600-75628800 |
Bivalent Enhancer |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
30 |
chr3:75628600-75628800 |
Active TSS |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
31 |
chr3:75628600-75628800 |
Flanking Bivalent TSS/Enh |
ES-UCSF4 Cell Line |
embryonic stem cell
|
32 |
chr3:75628600-75628800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
33 |
chr3:75628600-75628800 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
34 |
chr3:75628600-75628800 |
Enhancers |
Brain Hippocampus Middle |
brain
|
35 |
chr3:75628600-75628800 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
36 |
chr3:75628600-75629000 |
Flanking Bivalent TSS/Enh |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
37 |
chr3:75628600-75629000 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
38 |
chr3:75628600-75629000 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
39 |
chr3:75628600-75629000 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
40 |
chr3:75628600-75629200 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
41 |
chr3:75628600-75629200 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
42 |
chr3:75628600-75629200 |
Bivalent/Poised TSS |
Fetal Intestine Large |
intestine
|
43 |
chr3:75628600-75629400 |
Bivalent/Poised TSS |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
44 |
chr3:75628600-75629600 |
Bivalent/Poised TSS |
H1 Cell Line |
embryonic stem cell
|
45 |
chr3:75628600-75629600 |
Active TSS |
H9 Cell Line |
embryonic stem cell
|
46 |
chr3:75628600-75629600 |
Active TSS |
Cortex derived primary cultured neurospheres |
brain
|
47 |
chr3:75628600-75629600 |
Active TSS |
Fetal Brain Female |
brain
|
48 |
chr3:75628600-75629800 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
49 |
chr3:75628600-75629800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
50 |
chr3:75628600-75629800 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|